KLCMU
Kite Lake Capital Management (UK) Portfolio holdings
AUM
$62.8M
This Quarter Return
+3.06%
1 Year Return
+7.53%
3 Year Return
+54.03%
5 Year Return
+114.09%
10 Year Return
–
AUM
$31.6M
AUM Growth
+$31.6M
(-83%)
Cap. Flow
-$157M
Cap. Flow
% of AUM
-496.65%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
–
Reduced
–
Closed
6
Top Buys
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
$24.1M |
| 2 |
Qiagen
QGEN
|
$6.1M |
| 3 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$1.33M |
Top Sells
| 1 |
WBC
WABCO HOLDINGS INC.
WBC
|
$78.8M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$34.9M |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
$26.8M |
| 4 |
Pacific Biosciences
PACB
|
$19M |
| 5 |
PVTL
Pivotal Software, Inc.
PVTL
|
$14.6M |
Sector Composition
| 1 | Healthcare | 19.32% |
| 2 | Consumer Discretionary | 0% |
| 3 | Industrials | 0% |
| 4 | Materials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPO
1
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $24.1M | 76.46% | +207,382 | New | +$24.1M |
|
|
2
Qiagen
QGEN
$10.1B
| $6.1M | 19.32% | +180,455 | New | +$6.1M |
|
|
BMY.RT
3
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $1.33M | 4.22% | +442,340 | New | +$1.33M |
|
|
4
Pacific Biosciences
PACB
$393M
| – | – | -3,689,527 | Closed | -$19M |
|
|
WBC
5
DELISTED
WABCO HOLDINGS INC.
WBC
| – | – | -588,899 | Closed | -$78.8M |
|
|
GWR
6
DELISTED
Genesee & Wyoming Inc.
GWR
| – | – | -128,384 | Closed | -$14.2M |
|
|
PVTL
7
DELISTED
Pivotal Software, Inc.
PVTL
| – | – | -979,423 | Closed | -$14.6M |
|
|
ONCE
8
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – | -359,793 | Closed | -$34.9M |
|
|
VSM
9
DELISTED
Versum Materials, Inc.
VSM
| – | – | -506,989 | Closed | -$26.8M |
|